BASF

PharmTech and BASF Pharma Solutions are pleased to present a new virtual mini-conference addressing the topics and emerging trends across the pharma industry.

https://www.pharmtech.com/pt_w/emerging-trends


Each day of the conference features dynamic keynote speakers and presentations from industry leaders in the fields of drug development and formulations for patient compliance and convenience, partnerships with CDMOs/CMOs, digitalization in quality and regulatory and new perspectives on sustainability.


This conference is offered free of charge to attendees thanks to event sponsor BASF Pharma Solutions. Join us for the sessions that most interest you – or join for the entire conference!


The conference covers a range of topics across the pharma industry that will be interesting to:

Those working with or interested in drug development and formulations

Those working with or interested in digitalization topics such as machine learning

Those working with or interested in quality and regulatory

Those working with or interested in sustainability

DAY 1, June 27: Formulations for Patient Compliance and Convenience

Moderator: Jill Murphy, Editor of Pharmaceutical Technology

DAY 2, June 28: Partnerships: CDMO/CMO, Digitalization

Moderator: Feliza Mirasol, Editor of Pharmaceutical Technology

DAY 3, June 29: Perspectives on Sustainability in the Pharmaceutical Industry

Moderator: Felicity Thomas, Senior Editor of Pharmaceutical Technology

DAY ONE: Tuesday, June 27th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Formulations for Patient Compliance and Convenience

Keynote Presentation: Patient-centricity/Compliance/Convenience

Dr. Stephen W. Hoag, Professor, Department of Pharmaceutical Sciences; University of Maryland

The New Frontiers of Amorphous Solid Dispersions

Dr Catherine Tuleu, Professor in Pediatric Pharmaceutics; UCL School of Pharmacy

Joao Assis, MSc, Global Technical Marketing Manager;

DAY TWO: Wednesday, June 28th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Keynote Presentation: Partnerships and/or Digitalization in Pharma

Lindsay Johnson, PhD, Global Technical Marketing Manager; BASF Pharma Solutions


Speaker TBA
(Q&A – 5 min)

11:00-12:00 pm EDT


Panel discussion: Digitalization in Quality & Regulatory

Marius Stoffels; Merck KgaA, Darmstadt, Germany

DAY THREE: Thursday, June 29th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Perspectives on Sustainability in the Pharmaceutical Industry

Panel discussion: Sustainability Across the Value Chain

Hanns-Christian Mahler, CEO; Ten23 Health

Sebastien Taillemite, President; Ecovamed



Moderated by Felicity Thomas

10:00-10:45 am EDT


Dr. Fernando Muzzio, Distinguished Professor, Chemical and Biochemical Engineering; Rutgers University

Will Clark, Senior Director, CMC Sustainability; GSK


Global Technical Marketing Manager
BASF Pharma Solutions


Global Sustainability Manager, BASF Pharma Solutions
BASF Pharma Solutions



k
Senior Director, CMC Sustainability
GSK




Global Technical Marketing Manager
BASF Pharma Solutions

Webcasts

Emerging Trends in the Pharma Industry: Drug Development, Sustainability, and Digitalization

Articles

How Crystallization Inhibitors Play into SuperSEDDS

Podcasts

Crystallization inhibitors maintain super saturation of free drug during the absorption window upon oral administration. Formulators can achieve this by utilizing function excipients which provide solubilization enhancement and crystallization inhibition. We recently used the inhibitors to limit precipitation of drugs during the lipolysis of SEDDS and correlated with the Vivo performance. Additionally, these functional inhibitors effectively increased drug load and improved overall bioavailability by forming supersaturated-SEDDS. This podcast will cover the role of crystallization inhibitors in formulation and how to use in SEDDS formulation effetely.

Role of Crystallization Inhibitors in SuperSEDDS

Accelerate Time to Market with the Help of Virtual Formulation Design

Digitally Optimizing and Using QbD Principles in Topical Formulations

Applying Digital Solutions & QbD to Optimize Topical Product Development

Poorly soluble drugs for oral administration present unique formulation challenges, particularly during early development. Various formulation approaches are available, and numerous aspects must be evaluated in order to identify which choice is most suitable for a specific drug.

For this purpose, BASF has developed a science-based formulation tool that is available online 24/7 and guides formulators in the rational selection of an ideal dosage form and a suitable prototype drug formulation. For solubilization purposes, the following aspects and features are covered in this webcast:

Identification of solubility issues with the developability classification system

Assessment of molecular properties to identify suitable formulation approaches

Calculation and use of Hansen Solubility Parameters

Selection of suitable excipients for solubilization purposes

Learn how digital tools can help save time and facilitate the structured formulation development of poorly soluble drugs.

Via a guided case study, learn how the assessment of molecular properties can help to identifying solubility issues and to select suitable solubilization approaches.


Development BASF Pharma Solutions
BASF SE

Tuesday, October 19, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST
Join this webcast on digital tools for guiding the formulation development of poorly soluble drugs to learn about recent features of BASF’s virtual formulation assistant. Explore how to identify the most suitable formulation approach for your active ingredient.